T-lymphoblastoid lymphoma is a kind of non-Hodgkin’s lymphoma, and its prognosis can be divided into 4 categories: low risk, low intermediate risk, high intermediate risk, and high risk, with the cure rate of 87%, 67%, 55%, and 44% respectively. T-lymphoblastoid lymphoma is a kind of non-Hodgkin’s lymphoma, which is more prevalent in adolescents, males are more than females, and the lesions mainly involve lymph nodes, and it can develop into leukemia, and the treatment plan is a comprehensive treatment combining chemotherapy and radiotherapy mainly. In 1993, ShiPP et al. proposed the International Prognostic Index (IPI) for NHL, which classified T lymphoblastic lymphoma into four categories: low-risk, low-intermediate-risk, medium-intermediate-risk, and high-risk, with the cure rates of 87%, 67%, 55%, and 44%, respectively. T-lymphoblastic lymphoma is a malignant tumor that requires early and aggressive treatment to improve the cure rate of patients.